Healthways Inc (HWAY) 24.96 $HWAY Will Healthways (HWAY)

New Post Public Reply Private Reply Replies (0) Message Board

Sep 3, 2016 at 1:25 PM

Healthways Inc (HWAY) 24.96 $HWAY

Will Healthways (HWAY) Continue to Surge Higher?
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 9:42AM CDT
As of late, it has definitely been a great time to be an investor in Healthways, Inc. (HWAY)
HWAY: 24.96 (+0.10)

Teladoc Sees Increased Service Adoption, Expenses Stay High
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 8:06AM CDT
Teladoc (TDOC) went public last July with an IPO, is engaged in offering consumers virtual visits with physicians through voice or video.
TDOC: 18.50 (+0.52), ABCO: 42.22 (+0.04), HWAY: 24.96 (+0.10), AHS: 36.25 (+0.57)

Zacks.com featured highlights: Avid Technology, PCM, Amkor Technology, Alpha & Omega Semiconductor and Healthways
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 8:30AM CDT
Zacks.com featured highlights: Avid Technology, PCM, Amkor Technology, Alpha & Omega Semiconductor and Healthways
AMKR: 9.25 (+0.01), AVID: 9.12 (+0.08), PCMI: 18.36 (-0.17), HWAY: 24.96 (+0.10), AOSL: 21.59 (+0.22)

Technical Analysis and Fundamental Analysis Combined
Kevin Matras - ZACKS - Tue Aug 23, 3:45PM CDT
Technical Analysis and Fundamental Analysis Combined
AMKR: 9.25 (+0.01), AVID: 9.12 (+0.08), PCMI: 18.36 (-0.17), HWAY: 24.96 (+0.10), AOSL: 21.59 (+0.22)

The Zacks Analyst Blog Highlights: Tyson, AngloGold Ashanti, Central Garden & Pet, Deckers Outdoor and Healthways
Zacks Equity Research - Zacks Investment Research - Mon Aug 22, 8:30AM CDT
The Zacks Analyst Blog Highlights: Tyson, AngloGold Ashanti, Central Garden & Pet, Deckers Outdoor and Healthways
CENT: 25.85 (+0.17), AU: 17.04 (+0.42), HWAY: 24.96 (+0.10), DECK: 63.20 (-0.82), TSN: 76.44 (+0.96)

5 Absolute Best Stocks Ruling the Market
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 10:42AM CDT
The tumultuous ride in the market has left investors edgy about making the right stock picks for their portfolio. Stocks selected herein flaunt a Zacks Rank #1 and have a VGM Score of A.
CENT: 25.85 (+0.17), AU: 17.04 (+0.42), HWAY: 24.96 (+0.10), DECK: 63.20 (-0.82), TSN: 76.44 (+0.96)

Healthways: A Strong Buy on Solid Q2, Estimate Revision
Zacks Equity Research - Zacks Investment Research - Fri Aug 19, 7:54AM CDT
On Aug 16, Zacks Investment Research upgraded Healthways, Inc to a Zacks Rank #1 (Strong Buy).
BABY: 40.64 (+0.93), HWAY: 24.96 (+0.10), IDXX: 114.09 (+0.93), CRY: 16.23 (+0.39)

Zacks.com featured highlights: SodaStream International, Healthways, Quidel, Barracuda Networks and Matador Resources
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 8:30AM CDT
Zacks.com featured highlights: SodaStream International, Healthways, Quidel, Barracuda Networks and Matador Resources
CUDA: 23.96 (+0.27), QDEL: 21.58 (-0.16), HWAY: 24.96 (+0.10), MTDR: 23.72 (+0.72), SODA: 28.01 (+0.14)

For Healthcare Investing, Buy These 3 Medical Services Stocks
Zacks Premium Research - Zacks Investment Research - Wed Aug 17, 4:18PM CDT
The medical services space is gaining steam, so buy these top picks within the industry.
ABCO: 42.22 (+0.04), HWAY: 24.96 (+0.10), AHS: 36.25 (+0.57)

Healthways, SunPower, Berry Plastics, MarineMax and Trinseo highlighted as Zacks Bull and Bear of the Day
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 8:30AM CDT
Healthways, SunPower, Berry Plastics, MarineMax and Trinseo highlighted as Zacks Bull and Bear of the Day
BERY: 45.97 (+0.48), TSE: 58.51 (+0.92), HZO: 19.98 (+0.13), HWAY: 24.96 (+0.10), SPWR: 10.31 (+0.21)

5 Stocks with Earnings Surprise Potential to Beat the Market
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 7:41AM CDT
Invest in top-ranked stocks that are likely to beat earnings estimates in the upcoming releases.
CUDA: 23.96 (+0.27), QDEL: 21.58 (-0.16), HWAY: 24.96 (+0.10), MTDR: 23.72 (+0.72), SODA: 28.01 (+0.14)

Bull of the Day: Healthways Inc. (HWAY)
Brian Hamilton - Zacks Investment Research - Wed Aug 17, 6:01AM CDT
Bull of the Day: Healthways Inc. (HWAY)
HWAY: 24.96 (+0.10)

Strength Seen in Healthways Inc (HWAY): Stock Goes Up 7%
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 7:30AM CDT
Healthways Inc. (HWAY) shares rose over 7% in the last trading session.
ABCO: 42.22 (+0.04), HWAY: 24.96 (+0.10)

Healthways Has Returned 109.0% Since SmarTrend Recommendation (HWAY)
Comtex SmarTrend(R) - Tue Aug 16, 12:10AM CDT
SmarTrend identified an Uptrend for Healthways (NASDAQ:HWAY) on April 20th, 2016 at $11.40. In approximately 4 months, Healthways has returned 109.04% as of today's recent price of $23.82.
HWAY: 24.96 (+0.10)

Watch for Healthways to Potentially Pullback After Gaining 16.61% Yesterday
Comtex SmarTrend(R) - Wed Aug 10, 2:39PM CDT
Healthways (NASDAQ:HWAY) traded in a range yesterday that spanned from a low of $18.74 to a high of $22.76. Yesterday, the shares gained 16.6%, which took the trading range above the 3-day high of $18.09 on volume of 1.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HWAY: 24.96 (+0.10)

Healthways (HWAY) Q2 Earnings Shine, Revenues Miss Mark
Zacks Equity Research - Zacks Investment Research - Wed Aug 10, 9:05AM CDT
Healthways reported second-quarter 2016 earnings of 54 cents per share, which beat the Zacks Consensus Estimate by a stellar 53 cents.
HYH: 36.57 (+0.32), BABY: 40.64 (+0.93), BEAT: 18.82 (+0.12), HWAY: 24.96 (+0.10)

Healthways Names Robert E. Dries Chief Financial Officer
GlobeNewswire - Wed Aug 10, 9:00AM CDT
Healthways, Inc. (NASDAQ:HWAY) announced today that Robert E. Dries has been named executive vice president and chief financial officer, effective August 22, 2016. Dries will succeed Alfred Lumsdaine, who is expected to join Sharecare, Inc. in October 2016 in connection with the previously announced sale of Healthways' total population health services business to Sharecare.
OCR: 97.90 (-0.02), HWAY: 24.96 (+0.10)

Healthways Reports Second-Quarter 2016 Financial Results
GlobeNewswire - Tue Aug 09, 3:07PM CDT
Healthways (NASDAQ:HWAY) today announced financial results for the second quarter and six months ended June 30, 2016.
HWAY: 24.96 (+0.10)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

VeriSilicon's GLTiny: Game-Changer for Wearable Tech

Revolutionizing Wearable Graphics with GLTiny There's a fresh breeze blowing through the world of wearable tech, and VeriSilicon's GLTiny seems to be at the heart of it. When the silicon giant out of Shanghai tossed GLTiny into the mix, it wasn't just throwing another chip on the barbie. Oh no, this is a real pivot towards juicing up those smart gadgets strapped to your...

Factory-Built Homes Take Center Stage in New Doc Short

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Guidewire's 2026 Awards Highlight AI in Insurance Shift

AI Takes Center Stage at Guidewire's Annual Gala Change is constant, but when it comes with a potent mix of AI and insurance, you know things are about to get interesting. Guidewire Software (NYSE: GWRE) is tipping its hat to Beazley, Definity, and RCIS, the standouts at its annual Innovation Awards. Held during their CONNECTIONS Conference in Las Vegas, this year's...

UPM's WISA Group Demerger: A Strategic Shift

By Logan Wright Updated Oct 28, 2026 Category News Views 136

UPM's Bold Move on the Chessboard In a market that's no stranger to seismic tremors, UPM's decision to move forward with the partial demerger of its Kymmene Corporation is something that raises a few eyebrows. But hey, isn't shaking things up half the fun in this business? The Finnish Financial Supervisory Authority giving a thumbs-up to the supplement listing for WISA...

Markel Stays the Course: Solid Q3 Results in 2026

Markel Group's Steady Climb Doesn't Falter Diving right into it, Markel Group's latest figures prove they're not just treading water. The insurance giant, trading under NYSE:MKL, reported solid third quarter results for 2026. And while some numbers might not be breaking records, they sure paint a picture of a company that's weathering the market with some grit. The...

United Imaging Surges with 19.43% Revenue Growth in 2026

United Imaging's Remarkable Revenue Surge Coming out of Shanghai, we've got some major numbers to chew on. United Imaging Healthcare (688271.SH)—this isn't your run-of-the-mill medical tech firm—is bringing some serious heat to the market with a 19.43% bump in revenue. We're talking RMB 10.58 billion raked in over just the first nine months of 2026. Those are hefty...

Beta Bionics: Investors on Edge, Legal Moves Underway

A Tumultuous Time for Beta Bionics Investors Trouble's brewing for those holding Beta Bionics, Inc. (NASDAQ: BBNX) shares. This isn't just market jitters—it's a full-blown legal tussle. The shareholder-rights law honchos at Johnson Fistel are sounding the alarms, and investors better heed their call before the clock strikes November 3, 2026. There's a class action...

2026 Data Integration Stars: User Sentiments Revealed

Users Crown Data Integration Champions Right out of the gate, let's make one thing clear: when you're picking a data integration solution, you're essentially hitching your wagon to a vendor. This partnership, like any, can make or break your operations, and no one knows this better than the folks who've been through the trenches. Enter Infotech's 2026 Emotional Footprint...

MGM China Hits Record Highs Amid Market Challenges

Highs Amid Headwinds: MGM China's Standout Quarter Rolling into one's portfolio, MGM China isn't just coasting along—it's smashing some records, despite fierce headwinds. It's not all smooth sailing in Macau's gaming scene, but MGM China has hammered out its third-quarter results with gusto, setting new records for revenue and adjusted EBITDA. These folks aren't just...

Data Breach at Lumara Bio: Privacy Lawsuits Loom

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....